GGrantIndex
Sort

11,323 grants matching glioblastoma

Integrated Immune Engineering for Poor Prognosis Cancers

$1,869,132
David J Odde · University Of Minnesota · P01 · FY2023 · CA

Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.

$1,865,407
Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL

Center of Innovation for Brain Tumor Therapeutics

$1,861,663
Jann N Sarkaria · Mayo Clinic Rochester · U19 · FY2024 · CA

Mayo SPORE in Brain Cancer

$1,861,515
Brian Patrick O'Neill · Mayo Clinic Rochester · P50 · FY2012 · CA

Maximizing Local Access to Therapeutic Deliveries in Glioblastoma

$1,848,644
Waldemar Debinski · Wake Forest University Health Sciences · P01 · FY2019 · CA

Regulatory and epigenetic landscapes in biological discovery, diagnostics and disease mechanisms

$1,847,611
Laura L Elnitski · National Human Genome Research Institute · ZIA · FY2019 · HG

Human Blood-Brain Barrier Model for CNS Drug Translation

$1,844,274
Eric V Shusta · University Of Wisconsin-Madison · RC4 · FY2010 · AA

Molecular Pathogenesis of Neoplasia

$1,839,017
John Heiss · National Institute Of Neurological Disorders And Stroke · ZIA · FY2022 · NS

International Case Control Study of Malignant Glioma

$1,836,550
Melissa L Bondy · Baylor College Of Medicine · R01 · FY2014 · CA

MIT/Mayo Physical Sciences Center for Drug Distribution and Efficacy in Brain Tumors

$1,831,800
Forest M White · Massachusetts Institute Of Technology · U54 · FY2019 · CA

Maximizing Local Access to Therapeutic Deliveries in Glioblastoma

$1,827,419
Waldemar Debinski · Wake Forest University Health Sciences · P01 · FY2021 · CA

Neurosurgical Oncology Unit

$1,827,359
Desmond Brown · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS

Brain Tumor Clinical and Clinical Research Program

$1,822,715
Mark Gilbert · Division Of Basic Sciences - Nci · ZID · FY2021 · CA

Integrated Immune Engineering for Poor Prognosis Cancers

$1,811,915
David J Odde · University Of Minnesota · P01 · FY2024 · CA

Systems analysis of phenotypic switch in control of cancer invasion

$1,798,772
Andre Levchenko · Yale University · U54 · FY2020 · CA

Molecular Diagnostics Core Laboratory

$1,793,683
Mark Raffeld · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA

Maximizing Local Access to Therapeutic Deliveries in Glioblastoma

$1,793,324
Waldemar Debinski · Wake Forest University Health Sciences · P01 · FY2017 · CA

Regulatory and epigenetic landscapes in biological discovery, diagnostics and disease mechanisms

$1,792,057
Laura L Elnitski · National Human Genome Research Institute · ZIA · FY2018 · HG

Circumventing barriers to effective oncolytic virotherapy of malignant gliomas

$1,789,540
E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2021 · CA

Novel Therapeutics for Prion Diseases

$1,783,370
Stanley B Prusiner · University Of California, San Francisco · P01 · FY2013 · AG

Disease Status Drug Metabolism and New Drug Discovery

$1,782,050
Irving William Wainer · National Institute On Aging · ZIA · FY2012 · AG

Genetic and Molecular Epidemiology of Adult Glioma

$1,779,888
Margaret R. Wrensch · University Of California, San Francisco · R01 · FY2007 · CA

Synaptic Vesicle Exocytosis

$1,779,495
Ling Gang Wu · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS

Circumventing barriers to effective oncolytic virotherapy of malignant gliomas

$1,777,058
E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2020 · CA

Washington University Human Tumor Atlas Research Center

$1,771,881
Li Ding · Washington University · U2C · FY2020 · CA